A growing body of research suggests that GLP-1 drugs do more than control appetite and blood sugar. They could also fight ...

GLP-1-based therapies helped adults with overweight or obesity lose weight mainly by reducing fat mass and visceral adipose ...

Responding to consumer needs and aided by technology, the department’s influence now encompasses the entire store ...

ColonBroom is taking a more targeted approach. The company has launched an upgraded version of its GLP-1 Premium formula, ...

Amazon is launching a new GLP-1 program through One Medical and Amazon Pharmacy to streamline access to popular weight-loss ...

Roel van den Akker evaluates how blockbuster GLP-1s may shift broader commercialization trends. The GLP-1 market's evolution from a niche injectable class to a high-volume category is shifting trends ...

GLP-1 drugs are meant to treat metabolic diseases like diabetes and obesity. But as they become more available, some people might choose to use them even if they're not currently overweight. NPR's ...

Recent research and clinical updates highlight how GLP-1 receptor agonists are transforming diabetes and obesity care, with expanding uses from adolescents with type 2 diabetes to off-label ...

The ASA guidance suggests that patients on GLP-1 drugs should consult their healthcare providers well in advance of any ...

Hims & Hers Health shares declined on Thursday as investors reacted cautiously to the company’s latest expansion in GLP-1 ...